AAVT42 efficiently transduced neurons, improving cognitive functions in AD mouse models. Long-term BDNF expression alleviated cognitive impairments without affecting amyloid or tau pathology. Gene expression profiling indicated upregulation of synaptic genes, supporting neuroprotective effects. The gene discussed is MAPT; the disease is amyloidosis.